Latest Share Chat

REMOVE ADS

Immupharma Share News (IMM)

Immupharma Information

Share Price Information for Immupharma (IMM)

Share Price is delayed by 15 minutes

Get Live Data

4.40 -0.41 (-8.52%)

Bid:

4.40

Ask:

4.50

Spread: 0.10 (2.273%)

Market Cap: £27.45m

Last checked at -

Intraday Immupharma Share Chart

REMOVE ADS

Immupharma News

IN BRIEF: ImmuPharma to start next two phases of Lupuzor trial

ImmuPharma PLC - London-based drug discovery and development company - Will start phases two and three of the clinical trial for Lupuzor in the seocnd...

IN BRIEF: ImmuPharma rises on FDA feedback for neurological disease

ImmuPharma PLC - London-based drug discovery and development company - Gets positive support and guidance from the US Food & Drug Administration after...

IN BRIEF: ImmuPharma annual loss narrows as R&D spending reduced

ImmuPharma PLC - London-based drug discovery and development company - Posts no revenue for 2022, compared to GBP118,350 for 2021. Pretax loss narrows...

IN BRIEF: ImmuPharma says US FDA confirms date for Lupuzor meeting

ImmuPharma PLC - London-based drug discovery and development company - Notes the US Food & Drug Administration has set a date of June 7 for a type-C m...

ImmuPharma progresses P140 clinical programme with FDA

(Sharecast News) - Drug discovery and development company ImmuPharma announced positive progress in its late-stage P140 clinical programme on Tuesday,...

IN BRIEF: ImmuPharma shares up as FDA meeting for new drug confirmed

ImmuPharma PLC - London-based drug discovery and development company - Gets confirmation of a pre-investigational new drug meeting with the US Food & ...

AIM WINNERS & LOSERS: System1 rises after upturn in second half

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

LONDON MARKET OPEN: Stocks looking for direction before US inflation

(Alliance News) - Stock prices in London opened mixed on Wednesday, as caution prevailed ahead of a US inflation reading and minutes from the Federal ...